These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25474159)

  • 41. Complement involvement in bone homeostasis and bone disorders.
    Mödinger Y; Löffler B; Huber-Lang M; Ignatius A
    Semin Immunol; 2018 Jun; 37():53-65. PubMed ID: 29395681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.
    Wang D; DuBois RN
    Gastroenterol Clin North Am; 2010 Sep; 39(3):697-707. PubMed ID: 20951925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liver x receptors: a potential therapeutic target for modulating the atherosclerotic process.
    Parikh N; Frishman WH
    Cardiol Rev; 2010; 18(6):269-74. PubMed ID: 20926935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer.
    Bilotta MT; Petillo S; Santoni A; Cippitelli M
    Front Immunol; 2020; 11():584303. PubMed ID: 33224146
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liver X receptors as integrators of metabolic and inflammatory signaling.
    Zelcer N; Tontonoz P
    J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Updating osteoimmunology: regulation of bone cells by innate and adaptive immunity.
    Walsh MC; Takegahara N; Kim H; Choi Y
    Nat Rev Rheumatol; 2018 Mar; 14(3):146-156. PubMed ID: 29323344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsiao FC; Chen YJ
    Diabetes Res Clin Pract; 2013 Jun; 100(3):330-9. PubMed ID: 23369225
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease.
    Sanjurjo L; Aran G; Roher N; Valledor AF; Sarrias MR
    J Leukoc Biol; 2015 Aug; 98(2):173-84. PubMed ID: 26048980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin resistance: cross-talk between adipose tissue and skeletal muscle, through free fatty acids, liver X receptor, and peroxisome proliferator-activated receptor-α signaling.
    Olson AL
    Horm Mol Biol Clin Investig; 2013 Sep; 15(3):115-21. PubMed ID: 25436738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex-specific regulation of immune responses by PPARs.
    Park HJ; Choi JM
    Exp Mol Med; 2017 Aug; 49(8):e364. PubMed ID: 28775365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.
    Chinetti G; Fruchart JC; Staels B
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1128-31. PubMed ID: 17073767
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peroxisome proliferator-activated receptors and their relevance to dermatology.
    Friedmann PS; Cooper HL; Healy E
    Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Retinoid x receptor heterodimers in the metabolic syndrome.
    Shulman AI; Mangelsdorf DJ
    N Engl J Med; 2005 Aug; 353(6):604-15. PubMed ID: 16093469
    [No Abstract]   [Full Text] [Related]  

  • 57. Emerging molecules in the interface between skeletal system and innate immunity.
    Maruyama K; Akira S
    Pharmacol Res; 2015 Sep; 99():223-8. PubMed ID: 26141704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emerging roles of orphan nuclear receptors in regulation of innate immunity.
    Jin HS; Kim TS; Jo EK
    Arch Pharm Res; 2016 Nov; 39(11):1491-1502. PubMed ID: 27699647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mechanism of PUFA in regulating of gene expression].
    Tu WL; Sun Y; Geng Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):713-6. PubMed ID: 17713296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular responses to excess fatty acids: focus on ubiquitin regulatory X domain-containing protein 8.
    Kim H; Ye J
    Curr Opin Lipidol; 2014 Apr; 25(2):118-24. PubMed ID: 24378746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.